Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...

Entero Therapeutics (ENTO) announced that it has secured a $2M revolving loan agreement and subsequently appointed three new members to its ...

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO. Sayer, who will also join the company's board of directors, brings experience from his ...

Focus on executing Phase 3 safety study for lead candidate oral weekly risperidone (LYN-005) following positive data demonstrating efficacy compared to daily Risperdal Lyndra Therapeutics®, a ...

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO. Sayer, who will also ...

January 28, 2025--(BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical ... Under the leadership of outgoing President and CEO Jessica Ballinger, Lyndra completed the pivotal ...

PTD802 offers a promising neuroprotective treatment by promoting remyelination. Pheno Therapeutics’ CEO, Fraser Murray, PhD, expressed excitement about the MHRA approval. “This approval marks our ...

Dyno Therapeutics CEO and co-founder Eric Kelsic, PhD Last year, Dyno introduced Low-shot Efficient Accelerated Performance (LEAP SM) to efficiently generate capsid sequences with improved ...

Viking Therapeutics CEO Brian Lian said: "The VENTURE-Oral Phase 2 study represents an important milestone for the VK2735 program, as we advance two formulations of this compound into later-stage ...

Credit: PeopleImages.com – Yuri A/Shutterstock. Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO. Sayer, who will also join the company’s board of ...

Boston, USA-based biotech Averna Therapeutics (formerly known as Exsilio Therapeutics), revealed yesterday that it has appointed Thomas Barnes as its chief executive (CEO) and director. Dr Barnes ...